MC-FXN treatment of an FRDA mouse model using hydrodynamic tail vein injection resulted in an 18-fold and 3-fold increase of Frataxin in the mice livers and hearts, supporting the translational relevance of this modality.
N. Mozafari, Salomé Milagres, Raul Cuellar et al.· Gene Therapy· 0 citations
Antibody-oligonucleotide conjugates (AOCs) offer a promising solution to delivery challenges of therapeutic oligonucleotides. However, the relationship between their complex chemical architectures and biological activity remains poorly understood, limiting the development of important structure-function relationships....
O. Hayes, J. Rädler, E. Filipiak et al.· bioRxiv· 0 citations
It is demonstrated that lipid identity critically determines ASO efficacy, productive cellular uptake, and regional CNS engagement, emphasizing the need for context-specific lipid design in ASO therapeutic development.
S. Roudi, H. Y. Estupiñán, O. Saher et al.· bioRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.